MedPath

Clinical study to test and confirm the successful application of the technology in measuring Blood glucose without taking blood sample

Not Applicable
Conditions
Health Condition 1: E088- Diabetes mellitus due to underlying condition with unspecified complicationsHealth Condition 2: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2020/10/028454
Lead Sponsor
Miisky Technovation Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male, 18 to 65 years of age (both

inclusive), suffering from Type-1 & Type-2

Diabetes Mellitus.

2. Non-pregnant female subjects, 18 to 65 years

of age (both inclusive), suffering from

Type-1 & Type-2 Diabetes Mellitus.

3. Male & female meeting the above criteria &

willing to sign Informed Consent form

Exclusion Criteria

1. Subjects who do not meet any of the one or

more inclusion criteria

2. Subjects who meet the criteria but fail to

sign Informed consent form.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calibrate the device to predict results comparable to Venous blood results and Continuous Glucose monitoring device.Timepoint: Every 3 month for 1 year.
Secondary Outcome Measures
NameTimeMethod
To calibrate the device to predict SpO2, Hear Rate, Body Temprature & Hemoglobin results comparable to laboratory standards.Timepoint: 12 weeks.
© Copyright 2025. All Rights Reserved by MedPath